scispace - formally typeset
P

Peter G. Gibson

Researcher at University of Newcastle

Publications -  774
Citations -  53254

Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.

Papers
More filters
Journal ArticleDOI

Factors associated with 6‐min walk distance in severe asthma: A cross‐sectional study

TL;DR: Asthma symptoms and BMI were associated with exercise capacity in the overall population and Optimizing these factors may enhance the ability of patients to improve their exercise capacity and gain the associated positive health outcomes, but further studies are warranted.
Journal ArticleDOI

How does azithromycin improve asthma exacerbations? - Author's reply.

TL;DR: The IMPORT LOW technique uses standard tangential field-infield intensity-modulated radiation techniques with added simple shortening of field lengths and can be delivered easily using existing technologies and expertise that are already available in every radiotherapy department, without requirement for additional capital investment.
Journal ArticleDOI

Diagnosis and assessment of the asthmas.

TL;DR: In this article , the typical symptoms and abnormal physiology of variable airflow limitation permits the recognition of asthma, and the identification of further features, such as eosinophilic or type 2 inflammation, allows a compound diagnostic label of eOSINophilic asthma, conveys key information about future exacerbation risk and likely treatment responsiveness.
Proceedings ArticleDOI

Prematurity and respiratory function at 6 weeks of age in infants born to mothers with asthma during pregnancy and active tobacco smoking

TL;DR: In this paper, the effect of tobacco smoking on outcomes in offspring born to women with asthma in pregnancy who participated in the ongoing multicentre Breathing for Life trial, a controlled randomized trial comparing usual asthma management with inflammatory (Fraction of exhaled nitric oxide, FeNO)-guided asthma management.